Insider filing · FENC
Fennec Pharmaceuticals Inc.
FENC · Healthcare · 9 filings in 24 months
ticker →
Southpoint Capital Advisors LP sold $7.5M of Fennec Pharmaceuticals (FENC)
Executed Dec 24 2025, disclosed Dec 29 2025, 5 days later.
Value, as filed
$7.5M
1,000,000 sh × $7.50
Executed
Dec 24 2025
the trade date, as filed
Disclosed
Dec 29 2025
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SL
Southpoint Capital Advisors LP
10% owner
profile →
Southpoint Capital Advisors LP (10% owner) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Fennec Pharmaceuticals Inc. (FENC). The largest single filing was $7.5M of FENC (1,000,000 sh × $7.50, as filed), executed Dec 24 2025.
The name
FENCHealthcare · Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→